| -0.02 / -0.45%|
The 9 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 5.00, with a high estimate of 7.00 and a low estimate of 2.75. The median estimate represents a +13.38% increase from the last price of 4.41.
The current consensus among 9 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.